Molecular by PCR Testing

Stone Clinical Laboratories offers an advanced molecular testing solution for common infections using RT-PCR technology. This advanced technology accurately and definitively identifies the exact causative pathogen by its DNA/RNA. By identifying the pathogen(s), clinicians can treat patients quicker with the appropriate antibiotic.

The Stone Way

Molecular Testing by PCR – the better solution

  • Identifies causative organism/bacteria/pathogen by its DNA/RNA – which makes it possible to personalize diagnosis and treatment
  • 48 TAT, allowing for quicker treatment
  • Identifies poly-microbial infections
  • Traditional resistance gene mutations accompany UTI and wound patient results
  • Reduced risk of specimen contamination
  • >95% sensitivity and >95% specificity
  • Easy-to-interpret test results

Urinary Tract Infection Testing by PCR (UTI )

UTIs are among the most prevalent community acquired and hospital acquired infections, affecting almost 50% of the population at least once in their lifetime, and account for considerable amounts of morbidity and healthcare expenditure in the US, with an estimated annual cost of $3.5 billion.(1)

Traditional urine cultures missed 67% of uropathogens overall and 50% in the group with severe symptoms according to research published in the Journal of Clinical Microbiology; May 2016 T. Price et al.

Stone Clinical Laboratories UTI by PCR Testing Platform

UTIs are among the most prevalent community acquired and hospital acquired infections, affecting almost 50% of the population at least once in their lifetime, and account for considerable amounts of morbidity and healthcare expenditure in the US, with an estimated annual cost of $3.5 billion.(1)

Traditional urine cultures missed 67% of uropathogens overall and 50% in the group with severe symptoms according to research published in the Journal of Clinical Microbiology; May 2016 T. Price et al.

  • >95% sensitivity and >95% specificity
  • Includes Resistance Gene Analysis to assist with therapeutic selection
  • UTI by PCR testing covers > 90% of the most common causative bacteria found in uncomplicated UTIs
  • Testing for broad range of organisms helps identify potential poly-infections due to multiple organism detection
  • 48 hour turn around time (TAT), allowing for quicker treatment

UTI requisition

UTI sample report

STD/STI Testing

Sexually transmitted diseases (STDs) are major causes of acute illness and infertility worldwide. The World Health Organization (WHO) estimates 499 million new cases of STDs occur annually worldwide in adults aged 15-49 years. The performance of nucleic acid amplification tests (PCR) with respect to overall sensitivity, specificity, and ease of specimen transport is better than that of any of the other tests available for the diagnosis of chlamydia and gonorrhea infections (1)

  • Stone Swab and Bacterial Vaginitis Panels by PCR offer extensive infection selection with high performance characteristics and an average of 48 hr. turn around time.

Swab and BV sample report
Molecular Requisition

Nail Testing

Onychomycosis, the most common nail disease in the US, is a fungal infection of the fingernails or toenails that may involve any component of the nail unit, including the matrix, bed or plate. Treatment of onychomycosis is very expensive and requires long-term therapy, therefore, a proper diagnosis is needed.

  • Nail by PCR Testing identifies causative fungi by its DNA/RNA, which makes it possible to diagnosis onychomycosis accurately.
  • 48 hour turn around time (TAT), allowing for quicker treatment
  • Identifies poly-microbial infections
  • Accurate and reliable diagnosis (high sensitivity and specificity)

Nail sample report
Molecular Requisition

Respiratory Testing (RPP)

RPP testing through naspharyngeal swabs provides simultaneous qualitative detection and identification of multiple respiratory viruses and bacteria from patients whom are suspected for respiratory infections. The main purpose to is diagnose upper respiratory infections accurately and timely.

RPP sample report
Molecular Requisition

Wound Testing

Traditional cultures fail to grow more than 85% of organisms identified in chronic wounds. Cultures also have limitations which render them almost irrelevant for the diagnosis of polymicrobial clinical and biofilm infections.

  • Identifies causative organism/bacteria/pathogen by its DNA/RNA, which makes it possible to personalize antimicrobial therapy in wound care patients
  • 48 hour turn around time (TAT), allowing for quicker treatment
  • Identifies poly-microbial infections
  • Includes Resistance Gene Analysis to assist with therapeutic selection
  • >95% sensitivity and >95% specificity

Wound Sample Report
Molecular Requisition

Stone Clinical Laboratories